MMWR Morb Mortal Wkly Rep. 1995 Sep 22;44(37):684-5, 691.
As of December 1994, approximately one third (35.3%) of the 435,319 cases of acquired immunodeficiency syndrome (AIDS) reported among adults to CDC were associated with injecting-drug use (1). In addition, injection of illegal drugs is the risk behavior most frequently associated with heterosexual and perinatal transmission of human immunodeficiency virus (HIV) in the United States. The goal of syringe exchange programs (SEPs) is to reduce HIV transmission associated with drug injection by providing sterile syringes in exchange for use, potentially HIV-contaminated syringes. This report presents data from a recent survey of U.S. SEPs about their activities during January 1994-April 1995 and compares the findings with those of a 1993 survey (2).
截至1994年12月，疾病控制和预防中心（CDC）收到的报告显示，在向其报告的435319例成人获得性免疫缺陷综合征（AIDS）病例中，约三分之一（35.3%）与注射吸毒有关（1）。此外，在美国，注射非法药物是与人类免疫缺陷病毒（HIV）异性传播和围产期传播最常相关的风险行为。注射器交换项目（SEP）的目标是通过提供无菌注射器以换取可能被HIV污染的用过的注射器，来减少与药物注射相关的HIV传播。本报告展示了近期对美国SEP在1994年1月至1995年4月期间活动的调查数据，并将结果与1993年的一项调查结果进行了比较（2）。
